Severe carbamazepine toxicity induced by concurrent erythromycin therapy.
Mota
C R
CR
Carvalho
C
C
Mota
C
C
Ferreira
P
P
Vilarinho
A
A
Pereira
E
E
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D002648:Child; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D004917:Erythromycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D010612:Pharyngitis / Q000097:blood / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D002220:Carbamazepine; D004917:Erythromycin